Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: a report of three cases.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 20471553.
- Also identified by DOI 10.1016/j.jpainsymman.2009.09.015.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intraspinal opioid therapy has been increasingly used for the management of cancer pain refractory to traditional treatment. However, this approach may present challenges in patients with advanced cancer. Three cases are presented that highlight the challenges associated with using neuraxial analgesia to manage cancer pain that was felt to be "refractory" to conventional treatment. Before an invasive procedure, such as placement of a permanent intrathecal opioid delivery system, a rigorous assessment and treatment of total pain (physical, psychological, spiritual, social, and practical) by an interdisciplinary team would be prudent.
Medical subject headings
- Analgesics, Opioid
- Pain